Who
Werner Cautreels
Director
Company insider
Files Form 4 as: Chief Executive Officer, Traws Pharma; President and CEO, Cartesian Therapeutics; Director, Seres Therapeutics.
In numbers
- Trades disclosed
- 17
- Buys
- 1
- Sells
- 0
- Bought
- $186K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 25 Jun 2015
- Last trade
- 9 Jul 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 15 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 9 Jul 2026filed 15 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,258 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,258 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,496 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —4,874 at $0.00 | filing |
| 12 Oct 2025filed 15 Oct 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,530 at $0.00 | filing |
| 19 Jun 2025filed 23 Jun 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —96,348 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code M | $96396,348 at $0.01 | filing |
| 29 Dec 2024filed 27 Jan 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —96,348 | filing |
| 29 Dec 2024filed 27 Jan 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —96,348 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 13 Nov 2017filed 14 Nov 2017 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Bought | $186K20,000 at $9.31 | filing |
| 7 Jul 2017filed 11 Jul 2017 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 21 Jun 2016filed 23 Jun 2016 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,384 at $0.00 | filing |
| 25 Jun 2015filed 29 Jun 2015 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.